Skip to the main content
The Crier

NHS Framework Colorectal Cancer Drugs (See description below)

Your saved contracts

What the buyer wrote

NHS Framework for the supply of drugs licensed specifically to target epidermal growth factor receptor (EGFR)-expressing, RAS wild-type metastatic colorectal cancer

Bid for this and lost? There is a short window in which the decision can be questioned.

Awarded to

Amgen Ltd£75mends (30 Nov 2022)

Details

What the buyer calls it
NHS Framework Colorectal Cancer Drugs (See description below)
How they are buying
Advertised, open to anyoneAny supplier could bid without being invited first.
Type
goods
Work starts
1 Dec 2020
Work ends
30 Nov 2022

Who the buyer named

Wellington House, 133-135 Waterloo Rd was the named contact on this notice.

england.commercialqueries@nhs.net